Research & Development
Guardant set to present research data at ESMO 2022
An oral presentation and posters will share how the company's blood tests are utilized in cancer therapy trials, for predicting and monitoring treatment response in patients, and for identifying the genomic mechanisms of acquired resistance in cancer therapy, according to Guardant.
September 5, 2022
Viome launches early detection test for oral and throat cancers
The test leverages mRNA technology and an artificial intelligence platform to detect biomarkers for oral and throat cancer with 95% specificity and 90% sensitivity rates, the firm said.
August 3, 2022
AI can lend a hand in diagnosis, prognosis of oral SCC
After reviewing published studies in the literature on the use of AI with pathology and radiology images in patients with oral SCC, researchers from the University of Hong Kong concluded that the technology yielded good classification accuracy.
August 18, 2021
Viome's screening tool given 'breakthrough device' designation
Viome's technology and AI platform is designed to screen for oral cancer and throat cancer, which are traditionally diagnosed manually by a primary care clinician by visual or tactile senses in a subjective way, often going undiscovered.
May 6, 2021
Researchers get $3.3M to study AI in oral cancer
The U.S. National Cancer Institute awarded the five-year grant to a group led by Anant Madabhushi, PhD, the Donnell Institute Professor of Biomedical Engineering at CWRU and head of the Center for Computational Imaging and Personalized Diagnostics, and Dr. James Lewis Jr., a pathology, microbiology, and immunology professor at Vanderbilt University Medical Center.
January 5, 2021
ArcherDX teams with Ayala on companion tests
The deal will involve the application of ArcherDX's proprietary Anchored Multiplexed PCR (AMP) platform to detect mutations in cancers targeted by drugs in Ayala's pipeline. Ayala's focus is on the development of oral gamma secretase inhibitors for cancers driven by the activation of the Notch signaling pathway. Gamma secretase is an enzyme that activates the Notch pathway, leading to tumorigenesis.
July 7, 2019
Page 1 of 1